Gordon R Dreesman

Title: The Innovations of Gordon R Dreesman

Introduction

Gordon R Dreesman is a notable inventor based in Helotes, Texas. He is recognized for his contributions to the field of biomedical research, particularly in the development of synthetic peptides for diagnostic and vaccination purposes. His work has significant implications for the detection and prevention of viral diseases, including AIDS.

Latest Patents

Dreesman holds a patent for "Synthetic peptides and method of use for diagnosis and vaccination for - Composition and method for detection of and vaccination against the viral causative agents of AIDS and ARC." This innovative composition involves a synthetic peptide with an amino acid sequence that is homologous to the gp 41 and gp 120 subunits of the gp 160 envelope glycoprotein of HTLV-III, LAV, or ARC. The synthetic peptide is designed to elicit an immunogenic response in patients and can be conjugated to a carrier for use as a vaccine. Additionally, it can be utilized in diagnostic tests to detect antibodies against the viral agents of AIDS or ARC in biological fluid samples.

Career Highlights

Throughout his career, Dreesman has worked with esteemed organizations such as the Southwest Foundation for Biomedical Research and Harvard College. His research has contributed to advancements in the understanding and treatment of viral infections, showcasing his commitment to improving public health.

Collaborations

Dreesman has collaborated with notable colleagues, including Ronald C Kennedy and Myron E Essex. These partnerships have furthered his research efforts and expanded the impact of his innovations in the biomedical field.

Conclusion

Gordon R Dreesman is a distinguished inventor whose work in synthetic peptides has the potential to revolutionize the diagnosis and vaccination against AIDS and ARC. His contributions to biomedical research continue to influence the field and inspire future innovations.